US stocks ended the week up on Friday after stumbling with the hard sell-off of bank shares on Thursday. While many traders are still taking cues from Europe, the markets remain in neutral territory going into Monday’s trading. The top-performers from this trading week came from the biotechnology and medical appliance industries, as well as a gold futures contracts ETN.
The stocks and ETN in this week’s Big Weekly Winners: Swing Trading with PowerRatings all earned PowerRatings of 8 or higher one week ago on June 15th, 2012.
To learn more about PowerRatings, including how to swing trade stocks and ETFs with PowerRatings, click here.
Performance of 6/15/12 – 6/22/12 Trading Week
Rosetta Genomics, Ltd. (ROSG)
Shares of Rosetta Genomics, Ltd. spiked early in the week into overbought territory amid management announcing they had paid off secured loans and reclaimed unencumbered asset rights. ROSG settled by Friday and ended the week with a solid double-digit gain.
- 6/15/12 Entry Price: 9.43 with a PowerRating of 8
- 6/22/12 Exit Price: 12.84
- Gain: 36.16%
Accuray Incorporated (ARAY)
Accuray Incorporated shares rose steadily throughout the week and ended Friday tipping above its 200-day moving average. Developing and selling medical radiation equipment, ARAY closed the week with an over 8% gain in firmly overbought territory.
- 6/15/12 Entry Price: 5.99 with a PowerRating of 8
- 6/22/12 Exit Price: 6.49
- Gain: 8.35%
PowerShares DB Gold Double Short ETN (DZZ)
PowerShares DB Gold Double Short ETN has benefited from recent and substantial selloffs in gold, and swung sharply this week from oversold to overbought by Friday. DZZ shares garnered the biggest gain they’ve seen so far this month.
- 6/15/12 Entry Price: 4.79 with a PowerRating of 10
- 6/22/12 Exit Price: 5.14
- Gain: 7.31%
Learn how to swing trade using PowerRatings! Click here to launch your free trial to PowerRatings today. Free trials include full access to our entire database of stocks, ETFs and leveraged ETFs, as well as swing trader training videos.
Joshua Glasgall is Editor in Chief of Connors Research